Dr Antonio Galleu graduated in Medicine and became specialist in Haematology at the University of Sassari (Italy). He moved to London in 2010, when he started working in Francesco Dazzis lab and focused his research on the use of Mesenchymal stromal Cells (MSCs) for the treatment of immune-mediated diseases. He was awarded a Clinical Research Training Fellowship in 2016 and completed his PhD in 2019 at Kings College London. His studies unveiled the crucial role of MSC apoptosis for their immunosuppressive activity, thus advancing the understanding of MSC therapeutic properties in vivo. His contribution in the field was acknowledged in 2018 with the Jon J. van Rood Award granted by the European Society for Blood and Marrow Transplantation. He currently works at Kings College London as Clinical Research Fellow, funded with the John Goldman Fellowship for future Science and coordinates several projects on MSC therapeutics.